Van Zandwijk et al. [15] assessed the prognostic value of NSE and lactic dehydrogenase (LDH) in 42 locally advanced or metastatic NSCLC patients treated with chemotherapy. Here, ENO2 is linked to non-small cell lung carcinoma.